A Phase Ⅱ Clinical Study of Sanhuangjingshimingwan in Wet( Neovascular)Age-related Macular Degeneration(wAMD) Subjects
Clinical trial NCT04486963 · COMPLETED
Trial details
- NCT number
- NCT04486963
- Sponsor
- Tasly Pharmaceutical Group Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-24
- Primary completion
- 2022-11-01
- Enrollment
- 78
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.